Literature DB >> 8546230

E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures.

T J Montine1, V Amarnath, M E Martin, W J Strittmatter, D G Graham.   

Abstract

Lipid peroxidation increases with age in brain and is elevated further in Alzheimer's disease. E-4-hydroxy-2-nonenal and malondialdehyde are products of lipid peroxidation that can adduct and cross-link protein. Neurofibrillary tangles, a feature of Alzheimer's disease composed mostly of tau protein, contain cross-linked and ubiquitin-conjugated protein. In P19 neuroglial cultures, E-4-hydroxy-2-nonenal was a potent cytotoxin that cross-linked cytoskeletal proteins, including tau into high molecular weight species that were conjugated with ubiquitin. Malondialdehyde formed monoadducts with cell protein but did not cross-link and was not cytotoxic. A non-crosslinking analogue of E-4-hydroxy-2-nonenal was not cytotoxic. E-4-Hydroxy-2-nonenal may contribute to neurodegeneration and neurofibrillary tangle formation in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8546230      PMCID: PMC1861611     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

Review 1.  Protein oxidation and aging.

Authors:  E R Stadtman
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

2.  Fibroblasts that express aromatic amino acid decarboxylase have increased sensitivity to the synergistic cytotoxicity of L-dopa and manganese.

Authors:  T J Montine; T M Underhill; E Linney; D G Graham
Journal:  Toxicol Appl Pharmacol       Date:  1994-09       Impact factor: 4.219

3.  Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease.

Authors:  B Friguet; E R Stadtman; L I Szweda
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

Review 4.  Tau protein and the neurofibrillary pathology of Alzheimer's disease.

Authors:  M Goedert
Journal:  Trends Neurosci       Date:  1993-11       Impact factor: 13.837

5.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.

Authors:  P Mecocci; U MacGarvey; M F Beal
Journal:  Ann Neurol       Date:  1994-11       Impact factor: 10.422

6.  Intermediates in the Paal-Knorr synthesis of pyrroles. 4-Oxoaldehydes.

Authors:  V Amarnath; K Amarnath; W M Valentine; M A Eng; D G Graham
Journal:  Chem Res Toxicol       Date:  1995-03       Impact factor: 3.739

7.  Pyrrole formation from 4-hydroxynonenal and primary amines.

Authors:  L M Sayre; P K Arora; R S Iyer; R G Salomon
Journal:  Chem Res Toxicol       Date:  1993 Jan-Feb       Impact factor: 3.739

Review 8.  Radical AGEing in Alzheimer's disease.

Authors:  M A Smith; L M Sayre; V M Monnier; G Perry
Journal:  Trends Neurosci       Date:  1995-04       Impact factor: 13.837

9.  Tau self-association: stabilization with a chemical cross-linker and modulation by phosphorylation and oxidation state.

Authors:  R P Guttmann; A C Erickson; G V Johnson
Journal:  J Neurochem       Date:  1995-03       Impact factor: 5.372

10.  Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain.

Authors:  M Nishimura; H Tomimoto; T Suenaga; Y Namba; K Ikeda; I Akiguchi; J Kimura
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

View more
  24 in total

Review 1.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

2.  Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

Authors:  K S Montine; S J Olson; V Amarnath; W O Whetsell; D G Graham; T J Montine
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Mitochondrial abnormalities in Alzheimer's disease.

Authors:  K Hirai; G Aliev; A Nunomura; H Fujioka; R L Russell; C S Atwood; A B Johnson; Y Kress; H V Vinters; M Tabaton; S Shimohama; A D Cash; S L Siedlak; P L Harris; P K Jones; R B Petersen; G Perry; M A Smith
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

Review 4.  Biochemistry and pathology of radical-mediated protein oxidation.

Authors:  R T Dean; S Fu; R Stocker; M J Davies
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

5.  Central nervous system lipoproteins in Alzheimer's disease.

Authors:  T J Montine; K S Montine; L L Swift
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

6.  Neurodegenerative effects of recombinant HIV-1 Tat(1-86) are associated with inhibition of microtubule formation and oxidative stress-related reductions in microtubule-associated protein-2(a,b).

Authors:  Tracy R Butler; Katherine J Smith; Rachel L Self; Brittany B Braden; Mark A Prendergast
Journal:  Neurochem Res       Date:  2011-01-23       Impact factor: 3.996

7.  Herpes simplex virus type 1 infection induces oxidative stress and the release of bioactive lipid peroxidation by-products in mouse P19N neural cell cultures.

Authors:  Jerry H Kavouras; Emese Prandovszky; Klara Valyi-Nagy; S Krisztian Kovacs; Vaibhav Tiwari; Maria Kovacs; Deepak Shukla; Tibor Valyi-Nagy
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

Review 8.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

Review 9.  Oxidative stress and transcriptional regulation in Alzheimer disease.

Authors:  Qingli Shi; Gary E Gibson
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

10.  N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells.

Authors:  Rui Wang; James S Malter; Deng-Shun Wang
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.